Description

(Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide (TFA) (GN5) is a synthetic glycopeptide and can be used for detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients[1].—–C121H193N25O53.xC2HF3O2—-[1]Nakamura I, et al. Detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients by using synthetic hinge peptide and glycopeptide probes. Nephrology (Carlton). 2004;9(1):26-30.—-2845.96 (free acid)—-O=C(N1[C@@H](CCC1)C(N[C@@H](CO)C(N[C@@H]([C@H](O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(C)=O)C)C(N3[C@@H](CCC3)C(N4[C@@H](CCC4)C(N[C@@H]([C@H](O[C@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5NC(C)=O)C)C(N6[C@@H](CCC6)C(N[C@@H](CO[C@H]7O[C@H](CO)[C@H](O)[C@H](O)[C@H]7NC(C)=O)C(N8[C@@H](CCC8)C(N[C@@H](CO[C@H]9O[C@H](CO)[C@H](O)[C@H](O)[C@H]9NC(C)=O)C(N[C@@H]([C@H](O)C)C(N[C@@H](CCC)C(N[C@@H](CCC)C(N[C@@H]([C@H](O[C@H]O[C@H](CO)[C@H](O)[C@H](O)[C@H]NC(C)=O)C)C(N[C@@H](CCC)C(N[C@@H](CO)C(N[C@@H](CCC)C(N[C@@H](CO)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C(C)C)N.O=C(C(F)(F)F)O.[x]–Inflammation/Immunology–10 mM in DMSO–Others—-Others–Peptides